ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 392 filers reported holding ASTRAZENECA PLC in Q4 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $747,926 | -2.1% | 9,590 | -14.9% | 0.04% | -2.7% |
Q1 2024 | $763,814 | +0.3% | 11,274 | -0.3% | 0.04% | -7.5% |
Q4 2023 | $761,594 | -4.8% | 11,308 | -4.2% | 0.04% | -14.9% |
Q3 2023 | $799,638 | -5.4% | 11,808 | 0.0% | 0.05% | -4.1% |
Q2 2023 | $845,099 | -11.3% | 11,808 | -13.9% | 0.05% | -14.0% |
Q1 2023 | $952,236 | -3.6% | 13,719 | -5.8% | 0.06% | -6.6% |
Q4 2022 | $987,575 | +23.6% | 14,566 | 0.0% | 0.06% | +19.6% |
Q3 2022 | $799,000 | -17.1% | 14,566 | -0.2% | 0.05% | -13.6% |
Q2 2022 | $964,000 | -6.8% | 14,593 | -6.4% | 0.06% | +5.4% |
Q1 2022 | $1,034,000 | +10.5% | 15,593 | -3.0% | 0.06% | +16.7% |
Q4 2021 | $936,000 | -51.2% | 16,076 | -49.7% | 0.05% | -4.0% |
Q3 2021 | $1,918,000 | +89.2% | 31,936 | +88.7% | 0.05% | -3.8% |
Q2 2021 | $1,014,000 | +20.6% | 16,921 | 0.0% | 0.05% | +10.6% |
Q1 2021 | $841,000 | -0.6% | 16,921 | 0.0% | 0.05% | -6.0% |
Q4 2020 | $846,000 | -13.4% | 16,921 | -5.1% | 0.05% | -21.9% |
Q3 2020 | $977,000 | +3.5% | 17,832 | -0.1% | 0.06% | -5.9% |
Q2 2020 | $944,000 | +11.1% | 17,855 | -6.2% | 0.07% | -8.1% |
Q1 2020 | $850,000 | -13.4% | 19,033 | -3.2% | 0.07% | +5.7% |
Q4 2019 | $981,000 | +3.6% | 19,668 | -7.5% | 0.07% | -2.8% |
Q3 2019 | $947,000 | +17.5% | 21,258 | +8.8% | 0.07% | +16.1% |
Q2 2019 | $806,000 | +2.0% | 19,535 | 0.0% | 0.06% | -3.1% |
Q1 2019 | $790,000 | +6.5% | 19,535 | 0.0% | 0.06% | -8.6% |
Q4 2018 | $742,000 | -20.3% | 19,535 | -17.0% | 0.07% | -1.4% |
Q3 2018 | $931,000 | +32.6% | 23,535 | +17.7% | 0.07% | +26.8% |
Q2 2018 | $702,000 | -8.7% | 20,000 | -9.1% | 0.06% | -9.7% |
Q1 2018 | $769,000 | +0.8% | 22,000 | 0.0% | 0.06% | +1.6% |
Q4 2017 | $763,000 | +2.4% | 22,000 | 0.0% | 0.06% | 0.0% |
Q3 2017 | $745,000 | -0.7% | 22,000 | 0.0% | 0.06% | -3.2% |
Q2 2017 | $750,000 | -61.8% | 22,000 | -65.1% | 0.06% | -62.9% |
Q1 2017 | $1,962,000 | -6.0% | 63,000 | -17.6% | 0.17% | -12.8% |
Q4 2016 | $2,088,000 | +10.1% | 76,424 | +32.5% | 0.20% | +10.8% |
Q3 2016 | $1,896,000 | -0.3% | 57,686 | -8.4% | 0.18% | -1.7% |
Q2 2016 | $1,902,000 | +7.2% | 63,000 | 0.0% | 0.18% | -0.6% |
Q1 2016 | $1,774,000 | +28.0% | 63,000 | +219.9% | 0.18% | +30.4% |
Q4 2014 | $1,386,000 | +47.3% | 19,695 | -1.0% | 0.14% | -7.4% |
Q2 2013 | $941,000 | – | 19,901 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |